SCRP4203i
**Upon testing, the current lot of material did not meet WiCell`s standards for quality, and it is therefore unavailable. WiCell is working with the Provider to obtain replacement materials for distribution. To be notified of the status of this cell line please submit your information here.| Cell Line Alias | KBET4203i |
| Cell Type | Human iPS |
| Disease | None reported |
| Genetic Alteration/Mutation Information | Three sites within the 9p21 region were genotyped for each donor. This donor had a mix of genotypes at the 3 sites. |
| Sex | Male |
| Age at Collection | 21 Years |
| Ethnicity | None Reported |
| Ethnicity Information | n/a |
| Genetically Related Cell Lines | |
| Reprogramming Method | Non-Integrating (Episomal Plasmid: Oct4, Klf4, Sox2, L-Myc, shp53, Lin28) |
| Tissue Origin | Blood |
| Provider | The Scripps Research Institute - Dr. Eric Topol |
| dbGaP Data | |
| hPSCReg ID | |
| NIH Approval | |
| Pub Med Abstract | |
| Collection(s) | NHLBI Next Gen - Coronary artery disease and myocardial infarction (Dr. Eric Topol, Scripps Research Institute) |
Current Lot Information
| Lot Number | Culture Platform | Lot Description | Passage Number | Banked By | Protocol | Product Information & Testing |
|---|---|---|---|---|---|---|
| DB42086 | mTeSR1/Matrigel | 20 | Provider | WiCell Feeder Independent Pluripotent Stem Cell Protocol |
